Medicare Enrolled
Dr. Ezra Israel, M.D.
Internal Medicine · Brooklyn, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Israel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Israel?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Israel
Dr. Ezra Israel is an internal medicine specialist in Brooklyn, NY, with 17 years of NPI registration. Based on federal Medicare data, Dr. Israel performed 20,308 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Israel received a total of $7,290 from 40 pharmaceutical and/or device companies across 308 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Israel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years of NPI registration
▲ Top 1% volume in NY
$7,290 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗20,308
Medicare services
Top 1% in NY for internal medicine
Not available
Unique patients (not deduplicated)
$49
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
8,000 | $0 | $25 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
2,775 | $74 | $109 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,195 | $119 | $174 |
| COVID-19 immunoassay detection test A laboratory test that uses an immunoassay method to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) through direct visual observation. |
2,030 | $40 | $122 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
1,495 | $91 | $117 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
625 | $8 | $11 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
443 | $13 | $40 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
420 | $162 | $264 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
328 | $3 | $6 |
| Home dialysis services per month Monthly dialysis treatment provided in the patient's home for individuals aged 20 or older. |
303 | $271 | $442 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
235 | $14 | $51 |
| Dialysis services for patients 20 or older Dialysis treatment provided to patients aged 20 years or older, involving four or more physician visits per month. |
210 | $326 | $505 |
| Initial nursing facility care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 170 | $73 | $141 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
139 | $1 | $25 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
132 | $63 | $453 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
127 | $36 | $50 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
116 | $85 | $225 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 99 | $20 | $65 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
95 | $80 | $120 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
77 | $158 | $253 |
| Inhalation treatment for acute airway obstruction, first hour This procedure involves administering inhaled medication to treat acute airway obstruction during the first hour of treatment. |
69 | $58 | $350 |
| Dialysis services for adults, 2-3 visits per month This code covers dialysis services for patients aged 20 or older who have 2 to 3 physician visits per month. |
48 | $272 | $427 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
45 | $20 | $332 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
32 | $0 | $50 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
27 | $72 | $75 |
| Chronic kidney disease education session A one-hour individual educational session focused on the care of chronic kidney disease. |
27 | $101 | $500 |
| Influenza virus detection test A laboratory test that uses an immunoassay technique to detect the presence of the influenza virus through direct visual observation. |
24 | $16 | $100 |
| Electrocardiogram, 1-3 leads with physician review A heart rhythm test using one to three electrodes to record electrical activity, with interpretation by a physician. |
22 | $12 | $16 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.9% high complexity
45.2% medium
53.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,290
Total received (2018-2024)
Avg $1,041/year across 7 years
Top 12% in NY for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
308
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,012
2023
$1,518
2022
$1,126
2021
$1,013
2020
$598
2019
$367
2018
$655
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$416
Amgen Inc.
$223
GENZYME CORPORATION
$204
AKEBIA THERAPEUTICS INC
$176
Novartis Pharmaceuticals Corporation
$107
OPKO Pharmaceuticals, LLC
$106
Bayer Healthcare Pharmaceuticals Inc.
$100
Novo Nordisk Inc
$98
Mallinckrodt Hospital Products Inc.
$62
Abbott Laboratories
$49
Lilly USA, LLC
$48
Corcept Therapeutics
$47
E.R. Squibb & Sons, L.L.C.
$41
Intra-Sana Laboratories
$33
Fresenius USA Marketing, Inc.
$33
Vifor Pharma, Inc.
$29
Ardelyx, Inc.
$27
Boehringer Ingelheim Pharmaceuticals, Inc.
$26
Aurinia Pharma U.S., Inc.
$25
Xeris Pharmaceuticals, Inc.
$23
Dexcom, Inc.
$22
SHIELD THERAPEUTICS INC
$22
CALLIDITAS THERAPEUTICS US INC.
$21
ABBVIE INC.
$20
Astellas Pharma US Inc
$20
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$18
GlaxoSmithKline, LLC.
$14
Top 3 companies account for 41.9% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$858
Horizon Therapeutics plc
$517
GlaxoSmithKline, LLC.
$489
OPKO Pharmaceuticals, LLC
$470
Boehringer Ingelheim Pharmaceuticals, Inc.
$436
Mallinckrodt Hospital Products Inc.
$368
Novo Nordisk Inc
$353
Amgen Inc.
$348
Lilly USA, LLC
$333
Otsuka America Pharmaceutical, Inc.
$330
Vifor Pharma, Inc.
$311
GENZYME CORPORATION
$294
AKEBIA THERAPEUTICS INC
$259
Relypsa, Inc.
$243
Novartis Pharmaceuticals Corporation
$220
E.R. Squibb & Sons, L.L.C.
$188
Abbott Laboratories
$142
Bayer Healthcare Pharmaceuticals Inc.
$137
Fresenius USA Marketing, Inc.
$124
Bayer HealthCare Pharmaceuticals Inc.
$105
IDORSIA PHARMACEUTICALS US INC
$82
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$62
Regeneron Healthcare Solutions, Inc.
$61
Ardelyx, Inc.
$59
Corcept Therapeutics
$47
Calliditas Therapeutics US Inc.
$45
Aurinia Pharma U.S., Inc.
$44
Takeda Pharmaceuticals U.S.A., Inc.
$42
ABBVIE INC.
$42
PFIZER INC.
$37
DEXCOM, INC.
$35
Intra-Sana Laboratories
$33
Keryx Biopharmaceuticals, Inc.
$30
Xeris Pharmaceuticals, Inc.
$23
Dexcom, Inc.
$22
GRT US Holding, Inc.
$22
SHIELD THERAPEUTICS INC
$22
CALLIDITAS THERAPEUTICS US INC.
$21
Astellas Pharma US Inc
$20
Bardy Diagnostics, Inc.
$16
Top 3 companies account for 25.6% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ACTHAR · AURYXIA · Aimovig · Auryxia · BENLYSTA · BREZTRI · BRILINTA · CAMZYOS · Carnation Ambulatory Monitor · DEXCOM G6 TRANSMITTER · DUPIXENT · Dexcom G6 Transmitter · ELIQUIS · ENTRESTO · Entyvio · FARXIGA · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · IBSRELA · JARDIANCE · JESDUVROQ · JYNARQUE · KEVEYIS · KRYSTEXXA · Kerendia · Korlym · LEQVIO · LINZESS · LOKELMA · LUPKYNIS · MOUNJARO · Otezla · Ozempic · PRADAXA · Pacemakers · QUVIVIQ · Qutenza · RAYALDEE · RELTONE 200 MG · Rayaldee · Rybelsus · TARPEYO · TAVNEOS · TRULANCE · TRULICITY · Vafseo · Velphoro · Veltassa · Veozah · Wegovy · XIFAXAN
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
10,581
County median income
$78,548
Nearest hospital to ZIP centroid (approximate)
NEW YORK COMMUNITY HOSPITAL OF BROOKLYN, INC.
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Israel is a mixed practice specialist, with above-average Medicare volume (top 1% in NY), with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Israel experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Israel performed 8,000 iron sucrose injection (venofer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Israel receive payments from pharmaceutical companies?
Yes. Dr. Israel received a total of $7,290 from 40 companies across 308 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Israel's costs compare to other internal medicine physicians in Brooklyn?
Dr. Israel's average Medicare payment per service is $49. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Israel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Brooklyn
Browse internal medicine physicians in Brooklyn ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in NY
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in NY
Which NY internal medicine physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Horizon Therapeutics plc Payments to Doctors
See all physicians who received payments from Horizon Therapeutics plc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology